Your selections:
Angiotensin II, Sympathetic nerve activity and chronic heart failure
- Wang, Yutang, Seto, Sai-Wang, Golledge, Jonathan
Angiotensin converting enzyme 2 and atherosclerosis
- Wang, Yutang, Tikellis, Chris, Thomas, Merlin, Golledge, Jonathan
- Moran, Corey, Biros, Erik, Krishna, Smriti, Wang, Yutang, Tikellis, Chris, Moxon, Joseph, Cooper, Mark, Norman, Paul, Burrell, Louise, Thomas, Merlin, Golledge, Jonathan
Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation
- Krishna, Smriti, Seto, Sai-Wang, Jose, Roby, Biros, Erik, Moran, Corey, Wang, Yutang, Clancy, Paula, Golledge, Jonathan
It may be not suitable to perform renal denervation in renal arteries with significant stenosis
Limitations in current clinical trials on renal denervation
Single-sided renal denervation may be not suitable for patients with significant renal artery stenosis
It is urgent to investigate predictors of the response of blood pressure to renal denervation
Wnt signaling pathway inhibitor Sclerostin inhibits angiotensin II-induced aortic aneurysm and atherosclerosis
- Krishna, Smriti, Seto, Sai-Wang, Jose, Roby, Li, Jiaze, Morton, Susan, Biros, Erik, Wang, Yutang, Nsengiyumva, Vianne, Lindeman, Jan, Loots, Gabriela, Rush, Catherine, Craig, Jeffrey, Golledge, Jonathan
Are you sure you would like to clear your session, including search history and login status?